More: 30th Annual San Antonio Breast Cancer Symposium (SABCS)

Magnetic Resonance Imaging for Screening and Evaluation of Patients With Breast Cancer CME

December 13 - 16, 2007, San Antonio, Texas

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium.

Release Date: January 29, 2008; Valid for credit through January 29, 2009

Credits Available
Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

The content of this CME activity, "Magnetic Resonance Imaging for Screening and Evaluation of Patients With Breast Cancer," was developed by the faculty.

To participate in this activity: 1) review the target audience, learning objectives and author disclosures, 2) study the education content 3) answer the posttest and evaluation 4) view/print certificate View details

Contents of This CME Activity

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the San Antonio Breast Cancer Symposium. These materials and the related activity are not sanctioned by the San Antonio Breast Cancer Symposium or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Susan G. Komen
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Explain controversies and guidelines regarding use of MRI for breast cancer screening, determination of extent of disease, and monitoring treatment response
  2. Present pros and cons of MRI, both from an individual patient perspective and a public health policy perspective
Authors and Disclosures

Nancy E. Davidson, MD
Disclosure: Nancy E. Davidson, MD, has disclosed that she has received funding from Susan G. Komen for the Cure.


Monica Morrow, MD
Disclosure: Monica Morrow, MD, has disclosed no relevant financial relationships.


Cheryl L. Jernigan
Disclosure: Cheryl L. Jernigan has disclosed that she is a board member and patient advocate in grants review for Susan G. Komen for the Cure.


Eric L. Rosen, MD
Disclosure: Eric L. Rosen, MD, has disclosed that he has received research grants from Phillips Medical and is a member of an advisory panel for the US Food and Drug Administration.


Margie Miller
Disclosure: Margie Miller has disclosed no relevant financial relationships.


Jill W. Chamberlain
Disclosure: Jill W. Chamberlain has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.